Your web browser is out of date.
For your security and improved experience online, please update your browser.
Your web browser is out of date.
Diabetes on the Net is intended for healthcare professionals
This promotional webcast has been developed by Napp Pharmaceuticals Limited and Napp products will be discussed. The peer-reviewed publication discussed in this webcast was independently developed by the Improving Diabetes Steering Committee and the Committee remains independent from Napp in the delivery of their commentary on this peer-reviewed publication within this promotional webcast. Napp has fully funded the meeting and is responsible for the content, logistics and selection of speakers. OmniaMed has provided editorial, marketing and logistical support.
Join us for our upcoming promotional webcast taking place on the 28 January 2021 at 13:00 and 19:00
We are very pleased to announce that the Napp sponsored webcast ‘SGLT2 Inhibitors: Slowing of chronic kidney disease progression in type 2 diabetes’ is now open for registration.
Diabetic Kidney Disease (DKD) is of increasing importance to clinicians involved in the care and management of people with type 2 diabetes, and early detection is essential to improve outcomes.
This webcast has been developed to examine the latest guidance discussed in a recently published consensus statement.1
Attending will provide insights into:
This 45-minute webcast will be broadcast on 28 January 2021 at both 13.00 and 19.00. Each broadcast will be followed by a 15-minute live Q&A session where you can ask your questions to the expert speakers.
28 January 2021
13:00 and 19:00
GP Partner Woodlands Medical Centre, Cardiff
Sarah Davies is a GP in Cardiff with a special interest in diabetes. She qualified at the University of Wales College of Medicine in 2003 and initially trained as a physician, before making the move into general practice and never looked back! She has continued her interest in diabetes and presents regularly on the subject to colleagues at local and national meetings. She is passionate about general practice, particularly great quality diabetes care in the primary care setting. Dr Davies is the Clinical Director for Diabetes in primary care for Cardiff and Vale UHB. She is a Diabetes UK Clinical Champion, Primary Care Diabetes Society committee member and a presenter for NB Medical Hot Topics, leading their diabetes course.
GP Partner, North Berwick Health Centre; GPwSI in Diabetes & Medical Education
Kevin Fernando is a part-time GP Partner working at the coalface in North Berwick Health Centre, near Edinburgh. He is a Primary Care Diabetes Society committee member and also Scottish lead. Other roles include RCGP Clinical Advisor for diabetes and multimorbidity and also writer and presenter for the NB Medical Education Hot Topics GP Update courses. He is an alumnus of the Diabetes UK Clinical Champion programme.
Dr Fernando graduated from Edinburgh University in 2000 and holds both MRCGP and MRCP (UK) qualifications and has completed a Master’s degree in diabetes which he passed with distinction.
He has been elected to Fellowship of both the Royal College of General Practitioners and the Royal College of Physicians of Edinburgh for his work in diabetes and medical education. He is also a Member of the Academy of Medical Educators.
Professor of Medicine, University of Liverpool, Liverpool
John Wilding leads Clinical Research into Obesity, Diabetes and Endocrinology at the University of Liverpool. He graduated from Southampton University in 1985, where he continued his clinical training until moving to the Royal Postgraduate Medical School at Hammersmith Hospital, London where he undertook specialist training in Diabetes and Endocrinology, and three years laboratory-based research into the neurobiology of obesity and diabetes. He has been clinical academic at the University of Liverpool since 1996 and was appointed Professor of Medicine in 2005. He leads specialist services for severe obesity at University Hospital Aintree – designated a Centre for Obesity Management by the UK and European Associations for the Study of Obesity.
Professor Wilding’s research team focusses on developing new treatments and strategies to reduce the burden of obesity-related disease. He has published over three hundred papers, chapters and review articles related to his clinical and laboratory research interests, which include clinical trials in obesity and diabetes, adipocyte biology, functional neuroimaging of appetite in obesity and endocrine disease, and studies of metabolism in obesity and diabetes.
He is an Associate Editor of Diabetic Medicine, a Council member of the Royal College of Physicians and chairs the NIHR National Clinical Research Network Metabolic and Endocrine Speciality Group. He is a past Chair of the UK Association for the Study of Obesity and President Elect of the World Obesity Federation.
Session 1 (10 mins)
Session 2 (20 mins)
Session 3 (15 mins)
Session 4 (15mins)
28 January 2021
13:00 and 19:00
Date of preparation: January 2021 UK-INV-2000106
get the latest news
subscribe now
© Copyright OmniaMed Communications. All Rights Reserved
We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.
